Cited 0 times in

Reply to: Comments on "Randomized, two-arm, non-comparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045

DC Field Value Language
dc.contributor.author김성훈-
dc.contributor.author김유나-
dc.contributor.author박은향-
dc.contributor.author이정윤-
dc.date.accessioned2025-03-13T16:56:10Z-
dc.date.available2025-03-13T16:56:10Z-
dc.date.issued2024-02-
dc.identifier.issn0020-7136-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/204225-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherWiley-Liss-
dc.relation.isPartOfINTERNATIONAL JOURNAL OF CANCER-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAntineoplastic Combined Chemotherapy Protocols / adverse effects-
dc.subject.MESHCarcinoma, Ovarian Epithelial-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHNeoplasm Recurrence, Local / drug therapy-
dc.subject.MESHOvarian Neoplasms* / drug therapy-
dc.subject.MESHOvarian Neoplasms* / genetics-
dc.subject.MESHPhthalazines / adverse effects-
dc.titleReply to: Comments on "Randomized, two-arm, non-comparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Obstetrics and Gynecology (산부인과학교실)-
dc.contributor.googleauthorYoo-Na Kim-
dc.contributor.googleauthorJe-Gun Joung-
dc.contributor.googleauthorEunhyang Park-
dc.contributor.googleauthorJae-Weon Kim-
dc.contributor.googleauthorJung Bok Lee-
dc.contributor.googleauthorJinyeong Lim-
dc.contributor.googleauthorSunghoon Kim-
dc.contributor.googleauthorChel Hun Choi-
dc.contributor.googleauthorHee Seung Kim-
dc.contributor.googleauthorJongsuk Chung-
dc.contributor.googleauthorByoung-Gie Kim-
dc.contributor.googleauthorJung-Yun Lee-
dc.identifier.doi10.1002/ijc.34786-
dc.contributor.localIdA00595-
dc.contributor.localIdA05561-
dc.contributor.localIdA05760-
dc.contributor.localIdA04638-
dc.relation.journalcodeJ01092-
dc.identifier.eissn1097-0215-
dc.identifier.pmid37907776-
dc.identifier.urlhttps://onlinelibrary.wiley.com/doi/10.1002/ijc.34786-
dc.contributor.alternativeNameKim, Sung Hoon-
dc.contributor.affiliatedAuthor김성훈-
dc.contributor.affiliatedAuthor김유나-
dc.contributor.affiliatedAuthor박은향-
dc.contributor.affiliatedAuthor이정윤-
dc.citation.volume154-
dc.citation.number4-
dc.citation.startPage764-
dc.citation.endPage765-
dc.identifier.bibliographicCitationINTERNATIONAL JOURNAL OF CANCER, Vol.154(4) : 764-765, 2024-02-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Obstetrics and Gynecology (산부인과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.